CA Stock MarketDetailed Quotes

BBM Blueberries Medical Corp

Watchlist
  • 0.020
  • +0.005+33.33%
15min DelayMarket Closed Nov 27 12:18 ET
7.98MMarket Cap-2857P/E (TTM)

Blueberries Medical Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
69.69%-149.73K
53.56%-212.89K
9.26%-1.33M
6.69%-208.6K
24.23%-171.64K
8.18%-493.92K
4.62%-458.39K
12.60%-1.47M
56.09%-223.56K
48.21%-226.52K
Net income from continuing operations
33.43%-328.38K
41.44%-257.96K
-11.41%-1.64M
-5,825.86%-378.25K
-5.52%-323.37K
3.60%-493.27K
32.88%-440.48K
71.48%-1.47M
100.17%6.61K
28.50%-306.46K
Operating gains losses
----
----
86.19%-75.15K
76.37%-93.54K
78.66%-28.17K
----
----
-44.65%-544.04K
-16.80%-395.87K
-90.93%-132.01K
Depreciation and amortization
2,305.41%24.46K
91.75%26.95K
-49.47%149.74K
481.81%34.97K
-27.19%99.7K
-98.79%1.02K
-83.40%14.06K
-64.23%296.33K
-104.64%-9.16K
-49.83%136.93K
Asset impairment expenditure
----
----
--180.64K
----
----
----
----
--0
----
----
Remuneration paid in stock
----
----
160.60%20.78K
----
----
----
----
-176.20%-34.3K
----
----
Remuneration paid in stock
-23.24%13.4K
-24.35%15.65K
-16.45%111.45K
99.42%60.26K
-58.65%13.03K
-35.77%17.46K
-53.47%20.69K
139.28%133.4K
-40.03%30.22K
131.99%31.52K
Other non cashItems
-117.31%-19.73K
-83.05%20.21K
14.37%263.84K
130.21%13.08K
-84.72%17.56K
47.77%113.93K
45.43%119.27K
-20.98%230.7K
-177.08%-43.3K
44.11%114.89K
Change In working capital
134.62%62.18K
89.67%-17.75K
-321.08%-348.47K
-120.94%-46.55K
169.50%49.61K
-4.43%-179.61K
-178.99%-171.92K
77.72%-82.76K
558.09%222.24K
63.15%-71.39K
-Change in receivables
183.35%128.64K
56.23%-26.1K
----
----
67.97%-29.64K
-97.41%-154.34K
-57,243.27%-59.64K
-127.75%-19.74K
326.98%151.09K
4.05%-92.54K
-Change in inventory
119.07%17.22K
89.16%-5.01K
----
----
10.13%-15.95K
---90.3K
---46.19K
---12.31K
-93.34%5.43K
69.69%-17.74K
-Change in prepaid assets
217.82%22.59K
-25.50%-60.94K
----
----
158.34%52.45K
-72.09%-19.17K
-113.16%-48.56K
-63.36%-21.53K
-153.35%-7.91K
-16.32%20.3K
-Change in payables and accrued expense
-207.50%-105.92K
763.12%80.97K
----
----
515.46%42.03K
213.91%98.53K
56.37%-12.21K
93.05%-30.17K
141.45%77.49K
130.71%6.83K
-Change in other working capital
97.56%-350
-25.32%-6.67K
----
----
-93.87%721
-473.30%-14.33K
50.47%-5.32K
-78.95%1K
-158.05%-3.86K
124.56%11.77K
Cash from discontinued investing activities
Operating cash flow
69.69%-149.73K
53.56%-212.89K
9.26%-1.33M
6.70%-208.6K
24.23%-171.64K
8.18%-493.92K
4.62%-458.39K
12.60%-1.47M
56.09%-223.56K
48.21%-226.52K
Investing cash flow
Cash flow from continuing investing activities
-94.34%12.76K
0
275.63%382.92K
1,662.40%140.62K
19.53K
103.36%225.61K
-2.83K
309.01%101.94K
-273.29%-9K
0
Net PPE purchase and sale
-94.34%12.76K
--0
275.63%382.92K
1,662.40%140.62K
--19.53K
103.36%225.61K
---2.83K
1,168.54%101.94K
-1,955.67%-9K
--0
Cash from discontinued investing activities
Investing cash flow
-94.34%12.76K
--0
275.63%382.92K
1,662.40%140.62K
--19.53K
103.36%225.61K
---2.83K
309.01%101.94K
-273.29%-9K
--0
Financing cash flow
Cash flow from continuing financing activities
89.68%-1.24K
97.29%-498
-59.96%539.1K
-58.92%582.57K
69.30%-13.08K
-429.01%-12.01K
44.26%-18.38K
-51.32%1.35M
5,351.62%1.42M
-102.24%-42.62K
Net issuance payments of debt
89.68%-1.24K
97.29%-498
-1,093.38%-1.44M
-2,556.75%-1.4M
66.33%-13.08K
-429.01%-12.01K
44.26%-18.38K
12.56%-120.83K
-94.92%-52.64K
-27.50%-38.86K
Net common stock issuance
----
----
35.03%1.98M
----
----
----
----
-48.30%1.47M
----
----
Cash from discontinued financing activities
Financing cash flow
89.68%-1.24K
97.29%-498
-59.96%539.1K
-58.92%582.57K
69.30%-13.08K
-429.01%-12.01K
44.26%-18.38K
-51.32%1.35M
5,351.62%1.42M
-102.24%-42.62K
Net cash flow
Beginning cash position
-30.76%628.16K
-42.09%818.16K
5.18%1.41M
400.21%594.26K
34.21%626.95K
5.90%907.27K
5.18%1.41M
338.21%1.34M
-93.48%118.8K
16.14%467.13K
Current changes in cash
50.70%-138.2K
55.51%-213.39K
-1,916.64%-410.53K
-56.60%514.59K
38.62%-165.19K
33.78%-280.33K
6.61%-479.6K
-101.96%-20.36K
320.16%1.19M
-118.69%-269.14K
Effect of exchange rate changes
---37.49K
190.32%23.39K
-304.58%-184.08K
-368.35%-290.69K
267.32%132.51K
--0
-195.53%-25.89K
--89.98K
81.16%108.33K
-282.70%-79.19K
End cash Position
-27.83%452.46K
-30.76%628.16K
-42.09%818.16K
-42.09%818.16K
400.21%594.26K
34.21%626.95K
5.90%907.27K
5.18%1.41M
5.18%1.41M
-93.48%118.8K
Free cash from
70.76%-149.73K
53.84%-212.89K
7.74%-1.35M
6.48%-209.09K
23.86%-172.48K
4.80%-512.11K
4.03%-461.22K
15.07%-1.47M
56.30%-223.56K
51.08%-226.52K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 69.69%-149.73K53.56%-212.89K9.26%-1.33M6.69%-208.6K24.23%-171.64K8.18%-493.92K4.62%-458.39K12.60%-1.47M56.09%-223.56K48.21%-226.52K
Net income from continuing operations 33.43%-328.38K41.44%-257.96K-11.41%-1.64M-5,825.86%-378.25K-5.52%-323.37K3.60%-493.27K32.88%-440.48K71.48%-1.47M100.17%6.61K28.50%-306.46K
Operating gains losses --------86.19%-75.15K76.37%-93.54K78.66%-28.17K---------44.65%-544.04K-16.80%-395.87K-90.93%-132.01K
Depreciation and amortization 2,305.41%24.46K91.75%26.95K-49.47%149.74K481.81%34.97K-27.19%99.7K-98.79%1.02K-83.40%14.06K-64.23%296.33K-104.64%-9.16K-49.83%136.93K
Asset impairment expenditure ----------180.64K------------------0--------
Remuneration paid in stock --------160.60%20.78K-----------------176.20%-34.3K--------
Remuneration paid in stock -23.24%13.4K-24.35%15.65K-16.45%111.45K99.42%60.26K-58.65%13.03K-35.77%17.46K-53.47%20.69K139.28%133.4K-40.03%30.22K131.99%31.52K
Other non cashItems -117.31%-19.73K-83.05%20.21K14.37%263.84K130.21%13.08K-84.72%17.56K47.77%113.93K45.43%119.27K-20.98%230.7K-177.08%-43.3K44.11%114.89K
Change In working capital 134.62%62.18K89.67%-17.75K-321.08%-348.47K-120.94%-46.55K169.50%49.61K-4.43%-179.61K-178.99%-171.92K77.72%-82.76K558.09%222.24K63.15%-71.39K
-Change in receivables 183.35%128.64K56.23%-26.1K--------67.97%-29.64K-97.41%-154.34K-57,243.27%-59.64K-127.75%-19.74K326.98%151.09K4.05%-92.54K
-Change in inventory 119.07%17.22K89.16%-5.01K--------10.13%-15.95K---90.3K---46.19K---12.31K-93.34%5.43K69.69%-17.74K
-Change in prepaid assets 217.82%22.59K-25.50%-60.94K--------158.34%52.45K-72.09%-19.17K-113.16%-48.56K-63.36%-21.53K-153.35%-7.91K-16.32%20.3K
-Change in payables and accrued expense -207.50%-105.92K763.12%80.97K--------515.46%42.03K213.91%98.53K56.37%-12.21K93.05%-30.17K141.45%77.49K130.71%6.83K
-Change in other working capital 97.56%-350-25.32%-6.67K---------93.87%721-473.30%-14.33K50.47%-5.32K-78.95%1K-158.05%-3.86K124.56%11.77K
Cash from discontinued investing activities
Operating cash flow 69.69%-149.73K53.56%-212.89K9.26%-1.33M6.70%-208.6K24.23%-171.64K8.18%-493.92K4.62%-458.39K12.60%-1.47M56.09%-223.56K48.21%-226.52K
Investing cash flow
Cash flow from continuing investing activities -94.34%12.76K0275.63%382.92K1,662.40%140.62K19.53K103.36%225.61K-2.83K309.01%101.94K-273.29%-9K0
Net PPE purchase and sale -94.34%12.76K--0275.63%382.92K1,662.40%140.62K--19.53K103.36%225.61K---2.83K1,168.54%101.94K-1,955.67%-9K--0
Cash from discontinued investing activities
Investing cash flow -94.34%12.76K--0275.63%382.92K1,662.40%140.62K--19.53K103.36%225.61K---2.83K309.01%101.94K-273.29%-9K--0
Financing cash flow
Cash flow from continuing financing activities 89.68%-1.24K97.29%-498-59.96%539.1K-58.92%582.57K69.30%-13.08K-429.01%-12.01K44.26%-18.38K-51.32%1.35M5,351.62%1.42M-102.24%-42.62K
Net issuance payments of debt 89.68%-1.24K97.29%-498-1,093.38%-1.44M-2,556.75%-1.4M66.33%-13.08K-429.01%-12.01K44.26%-18.38K12.56%-120.83K-94.92%-52.64K-27.50%-38.86K
Net common stock issuance --------35.03%1.98M-----------------48.30%1.47M--------
Cash from discontinued financing activities
Financing cash flow 89.68%-1.24K97.29%-498-59.96%539.1K-58.92%582.57K69.30%-13.08K-429.01%-12.01K44.26%-18.38K-51.32%1.35M5,351.62%1.42M-102.24%-42.62K
Net cash flow
Beginning cash position -30.76%628.16K-42.09%818.16K5.18%1.41M400.21%594.26K34.21%626.95K5.90%907.27K5.18%1.41M338.21%1.34M-93.48%118.8K16.14%467.13K
Current changes in cash 50.70%-138.2K55.51%-213.39K-1,916.64%-410.53K-56.60%514.59K38.62%-165.19K33.78%-280.33K6.61%-479.6K-101.96%-20.36K320.16%1.19M-118.69%-269.14K
Effect of exchange rate changes ---37.49K190.32%23.39K-304.58%-184.08K-368.35%-290.69K267.32%132.51K--0-195.53%-25.89K--89.98K81.16%108.33K-282.70%-79.19K
End cash Position -27.83%452.46K-30.76%628.16K-42.09%818.16K-42.09%818.16K400.21%594.26K34.21%626.95K5.90%907.27K5.18%1.41M5.18%1.41M-93.48%118.8K
Free cash from 70.76%-149.73K53.84%-212.89K7.74%-1.35M6.48%-209.09K23.86%-172.48K4.80%-512.11K4.03%-461.22K15.07%-1.47M56.30%-223.56K51.08%-226.52K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data